ArticleCureus2026
Chronic Foreign Body Inflammatory Response in Textiloma Formation: Case Report and Analysis of Current Evidence.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A gossypiboma (GPB), also referred to as a textiloma (TXT), is a mass formed as a result of the body's inflammatory and granulomatous response to retained surgical textile material (RSTM), most commonly gauze or mesh fibers. Its reported incidence ranges from 1 in 1,000 to 1 in 10,000 surgical procedures, although the true frequency is believed to be significantly higher due to underreporting related to medicolegal concerns. This entity is clinically important because it may mimic more common postoperative complications such as abscess (ABS), seroma (SER), or mesh infection (MI), frequently leading to diagnostic delay and unnecessary morbidity. The purpose of this report is to present an uncommon instance of mesh-associated textiloma (MAT) following ventral hernia repair with polypropylene mesh (PPM) and to highlight its radiologic, histopathologic, and clinical features that allow differentiation from other postoperative collections. A 39-year-old female patient with a history of ventral hernia underwent surgical repair with mesh implantation. Postoperatively, she developed persistent umbilical discharge and, three months later, progressive abdominal fluid leakage. Contrast-enhanced computed tomography (CECT) revealed a well-defined hypodense intraperitoneal collection measuring 80 × 64 × 40 mm with a fistulous tract (FT) extending to the abdominal wall, without evidence of systemic inflammatory dissemination. These features, particularly the encapsulated nature of the collection and the organized fistulization pattern, were highly suggestive of a chronic foreign-body reaction (FBR) rather than an acute ABS, which typically presents with diffuse inflammatory infiltration, or MI, which is associated with diffuse mesh thickening and surrounding cellulitis. A second surgical exploration was performed, and the resected specimen underwent histopathological examination (HPE), which demonstrated foreign-body granulomatous inflammation (FBGI) with multinucleated giant cells (MGC) surrounding textile fibers embedded in fibrous tissue, consistent with MAT, and without evidence of dysplasia or malignancy. Following complete excision and aponeurotic closure, the patient recovered uneventfully, with no recurrence during follow-up. This case reinforces that MAT should be included in the differential diagnosis of persistent postoperative collections after mesh-based hernia repair and demonstrates that characteristic CECT findings combined with timely surgical management are essential to reduce morbidity and prevent long-term complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.